| Trabectedin studied in …STUDIED_INderived74 of 74show fewer |
|---|
| → studied in | NCT06524583Phase 2 · recruiting Interest of Post-operative Chemotherapy in Patients With Localised Uterine Leiomyosarcoma Suspected of Having a High Risk of Recurrence Based on a Biological Test Performed on the Tumour · 74 trials list this drug (9 active) | — | — | Uterine Corpus Leiomyosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02672527Phase 3 · completed Trial Comparing Trabectedin to the Best Supportive Care in Patients With Sarcoma · 74 trials list this drug (9 active) | — | — | Soft Tissue Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06263231Phase 3 · recruiting A Study to Investigate Efficacy & Safety of Intratumoral INT230-6 Compared to US Standard of Care in Adults With Soft Tissue Sarcomas (INVINCIBLE-3) · 74 trials list this drug (9 active) | — | — | Soft Tissue Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07444619Phase 1 · recruiting A Phase I Study of Pazopanib in Combination With Trabectedin, Ipilimumab and Nivolumab (TraPIN) in Pediatric and Young Adult Patients With Recurrent Soft Tissue Sarcomas · 74 trials list this drug (9 active) | — | — | Soft Tissue Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04305548Phase 2 · recruiting Study on Trabectedin in Advanced Rearranged Mesenchymal Chondrosarcoma · 74 trials list this drug (9 active) | — | — | Mesenchymal Chondrosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04383119Phase 2 · recruiting Trial in Patients With Metastatic or Locally Advanced Leiomyosarcoma · 74 trials list this drug (9 active) | — | — | Soft Tissue Sarcoma,Ovarian Leiomyosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01303094Phase 2 · completed Continuing vs Intermittent Trabectedin in Patients With Advanced Soft Tissue Sarcoma · 74 trials list this drug (9 active) | — | — | Soft Tissue Sarcoma,Uterine Corpus Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04008238NA · completed Prospective Identification of Predictive Biomarkers of Trabectedin Efficacy in Non-L Soft-tissue Sarcoma Patients · 74 trials list this drug (9 active) | — | — | Sarcoma,Soft Tissue Sarcoma,Solitary Fibrous Tumor+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04794127Phase 2 · completed Study on Trabectedin in Combination With Pioglitazone in Patients Myxoid Liposarcomas With Stable Disease After T Alone. · 74 trials list this drug (9 active) | — | — | Round Cell Liposarcoma,Dedifferentiated Liposarcoma,Myxoid Liposarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04067115Phase 1/Phase 2 · completed SARC037: A Phase I/II Study to Evaluate the Safety of Trabectedin in Combination With Irinotecan in Ewing Sarcoma Patients · 74 trials list this drug (9 active) | — | — | Ewing Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01710176Phase 3 · completed Localized High-Risk Soft Tissue Sarcomas Of The Extremities And Trunk Wall In Adults: An Integrating Approach Comprising Standard Vs Histotype-Tailored Neoadjuvant Chemotherapy · 74 trials list this drug (9 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04076579Phase 2 · completed Trabectedin in Combination With Olaparib in Advanced Unresectable or Metastatic Sarcoma · 74 trials list this drug (9 active) | — | — | Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02234050Phase 2 · completed Trabectedin for Recurrent Grade II/III Meningioma · 74 trials list this drug (9 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05597917Phase 3 · recruiting tTF-NGR Randomized Study - STS · 74 trials list this drug (9 active) | — | — | Soft Tissue Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03138161Phase 1/Phase 2 · recruiting SAINT:Trabectedin, Ipilimumab and Nivolumab for Previously Treated Advanced Soft Tissue Sarcoma · 74 trials list this drug (9 active) | — | — | Soft Tissue Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04535271Phase 2 · recruiting Metronomic Trabectedin, Gemcitabine, and Dacarbazine for Soft Tissue Sarcoma · 74 trials list this drug (9 active) | — | — | Leiomyosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04979442Phase 3 · terminated Treatment of Milademetan Versus Trabectedin in Patient With Dedifferentiated Liposarcoma · 74 trials list this drug (9 active) | — | — | Dedifferentiated Liposarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03023124Phase 2 · completed Study With Trabectedin Versus Adriamycin Plus Dacarbazine, in Patients With Advanced Solitary Fibrous Tumor · 74 trials list this drug (9 active) | — | — | Solitary Fibrous Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03127215Phase 2 · completed Study of Olaparib/Trabectedin vs. Doctor's Choice in Solid Tumors · 74 trials list this drug (9 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03884972Phase 1 · withdrawn Trabectedin and Venetoclax in Treating Patients With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma Resistant or Intolerant to a BTK Inhibitor · 74 trials list this drug (9 active) | — | — | Chronic Lymphocytic Leukemia,Small Lymphocytic Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02367924completed Efficacy and Safety of Trabectedin (Yondelis®) in Patients With Advanced Soft Tissue Sarcoma · 74 trials list this drug (9 active) | — | — | Soft Tissue Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02275286Phase 1/Phase 2 · recruiting Trabectedin Plus Radiotherapy in Soft Tissue Sarcoma Patients · 74 trials list this drug (9 active) | — | — | Liposarcoma,Soft Tissue Sarcoma,Leiomyosarcoma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05131386Phase 2 · unknown Multicohort Trial of Trabectedin and Low-dose Radiation Therapy in Advanced/Metastatic Sarcomas · 74 trials list this drug (9 active) | — | — | Bone Neoplasm,Soft Tissue Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02359474Phase 2 · unknown Hyper-Thermia Enhanced Anti-tumor Efficacy of Trabectedin · 74 trials list this drug (9 active) | — | — | Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03590210Phase 2 · completed Combined Treatment With Nivolumab and Trabectedin in Patients With Metastatic or Inoperable Soft Tissue Sarcomas · 74 trials list this drug (9 active) | — | — | Adult Soft Tissue Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03074318Phase 1/Phase 2 · terminated Avelumab and Trabectedin in Treating Patients With Liposarcoma or Leiomyosarcoma That is Metastatic or Cannot Be Removed by Surgery · 74 trials list this drug (9 active) | — | — | Liposarcoma,Leiomyosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03690739Phase 3 · terminated Evaluation of Symptom Benefit Rate of Trabectedin/PLD in Patients With Recurrent Ovarian Cancer · 74 trials list this drug (9 active) | — | — | Ovarian Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01379989Phase 3 · completed INOVATYON STUDY -International, Randomized Study in Patients With Ovarian Cancer · 74 trials list this drug (9 active) | — | — | Malignant Ovarian Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02247544Phase 2 · completed Efficacy Study on Trabectedin in Retroperitoneal Leiomyosarcoma and Well Differentiated/Dedifferentiated Liposarcoma · 74 trials list this drug (9 active) | — | — | Liposarcoma,Leiomyosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02825420completed Non-interventional European Study of Trabectedin + PLD in the Treatment of Relapsed Ovarian Cancer (ROC) Patients · 74 trials list this drug (9 active) | — | — | Malignant Ovarian Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02903004Phase 3 · completed Trial on Trabectedin (ET-743) vs Clinician's Choice Chemotherapy in Recurrent Ovarian, Primary Peritoneal or Fallopian Tube Cancers of BRCA Mutated or BRCAness Phenotype Patients · 74 trials list this drug (9 active) | — | — | Ovarian Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02993705Phase 2 · completed Trial On Trabectedin In The Treatment Of Advanced Uterine And Ovarian Carcinosarcoma (CS) · 74 trials list this drug (9 active) | — | — | Carcinosarcoma,Ovarian Carcinosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02398058Phase 1 · completed Trabectedin Plus Olaparib in Metastatic or Advanced Sarcomas (TOMAS) · 74 trials list this drug (9 active) | — | — | Bone Neoplasm,Soft Tissue Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02929394Phase 3 · terminated Trabectedin Maintenance Post 1st-line in STS · 74 trials list this drug (9 active) | — | — | Soft Tissue Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04394728completed Pharmacometabolomic of Trabectedin in Soft Tissue Patients · 74 trials list this drug (9 active) | — | — | Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02194231Phase 2 · completed ATREUS - Phase II Study on the Activity of Trabectedin in Patients With Malignant Pleural Mesothelioma (MPM) · 74 trials list this drug (9 active) | — | — | Pleural Malignant Mesothelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03397186Phase 2 · withdrawn Immune Changes Following Trabectedin in Patients With Metastatic or Unresectable Sarcoma · 74 trials list this drug (9 active) | — | — | Round Cell Liposarcoma,Soft Tissue Sarcoma,Myxoid Liposarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02793050completed Retrospective Study of Trabectedin in Soft Tissue Sarcomas · 74 trials list this drug (9 active) | — | — | Soft Tissue Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01846611Phase 3 · completed A Study Comparing the Combination of Trabectedin (YONDELIS) and DOXIL/CAELYX With DOXIL/CAELYX for the Treatment of Advanced-Relapsed Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancer · 74 trials list this drug (9 active) | — | — | Peritoneal Neoplasm,Fallopian Tube Neoplasm,Ovarian Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03437070Phase 1 · withdrawn Trabectedin, Doxorubicin and Olaratumab in Patients With Metastatic or Recurrent Leiomyosarcoma · 74 trials list this drug (9 active) | — | — | Leiomyosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00070109Phase 2 · completed Trabectedin in Treating Young Patients With Recurrent or Refractory Soft Tissue Sarcoma or Ewing's Family of Tumors · 74 trials list this drug (9 active) | — | — | Ewing Sarcoma,Peripheral Primitive Neuroectodermal Tumor,Childhood Soft Tissue Sarcoma+1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00569673Phase 2 · completed Docetaxel, Trabectedin, and G-CSF or Pegfilgrastim in Treating Patients With Recurrent or Persistent Ovarian Epithelial Cancer, Primary Peritoneal Cavity Cancer, or Fallopian Tube Cancer · 74 trials list this drug (9 active) | — | — | Malignant Fallopian Tube Neoplasm,Malignant Ovarian Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01692678Phase 3 · completed A Study of Trabectedin (YONDELIS) in Patients With Locally Advanced or Metastatic Liposarcoma or Leiomyosarcoma · 74 trials list this drug (9 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02066675Phase 2 · completed Trabectedin First Line Therapy In Unfit Sarcoma Study · 74 trials list this drug (9 active) | — | — | Soft Tissue Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00379145Phase 2 · completed Trabectedin in Treating Patients With Advanced, Persistent, or Recurrent Leiomyosarcoma of the Uterus · 74 trials list this drug (9 active) | — | — | Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02249702Phase 2 · completed Activity of Trabectedin or Gemcitabine + Docetaxel in Uterine Leiomyosarcoma · 74 trials list this drug (9 active) | — | — | Leiomyosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00210665no longer available A Study to Provide Access to Trabectedin in Participants With Locally Advanced or Metastatic Soft Tissue Sarcoma Who Have Persistent or Recurrent Disease and Who Are Not Expected to Benefit From Currently Available Standard of Care Treatment · 74 trials list this drug (9 active) | — | — | Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01453283Phase 1 · completed Tabectedin to Treat Children and Adolescents With Cancer · 74 trials list this drug (9 active) | — | — | Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01343277Phase 3 · completed A Study of Trabectedin or Dacarbazine for the Treatment of Patients With Advanced Liposarcoma or Leiomyosarcoma · 74 trials list this drug (9 active) | — | — | Leiomyosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01273493Phase 1 · completed A Pharmacokinetic Study of Trabectedin in Patients With Advanced Malignancies and Hepatic Dysfunction · 74 trials list this drug (9 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00796120Phase 3 · completed An Efficacy and Safety Study of Trabectedin Versus Doxorubicin-Based Chemotherapy in Participants With Translocation-Related Sarcomas (TRS) · 74 trials list this drug (9 active) | — | — | Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01104298Phase 2 · terminated Doxorubicin vs. Trabectedin Plus Doxorubicin in Non Operable and/or Metastatic STS · 74 trials list this drug (9 active) | — | — | Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01267084Phase 1/Phase 2 · completed A Study to Assess the Potential Effects of Ketoconazole on the Pharmacokinetics of Trabectedin in Patients With Advanced Malignancies · 74 trials list this drug (9 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00027508Phase 2 · terminated Ecteinascidin 743 in Treating Patients With Malignant Mesothelioma · 74 trials list this drug (9 active) | — | — | Malignant Mesothelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00060944Phase 2 · completed A Study to Assess Treatment With 2 Different Dosing Schedules of Trabectidin Administered to Patients With Advanced Cancer · 74 trials list this drug (9 active) | — | — | Liposarcoma,Leiomyosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01339754Phase 2 · completed Trabectedin in Treating Patients With Metastatic Pancreatic Cancer After First-Line Chemotherapy · 74 trials list this drug (9 active) | — | — | Malignant Pancreatic Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01189253Phase 2/Phase 3 · terminated Doxorubicin Hydrochloride or Trabectedin in Treating Patients With Previously Untreated Advanced or Metastatic Soft Tissue Sarcoma · 74 trials list this drug (9 active) | — | — | Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00113607Phase 3 · completed An Efficacy and Safety Study for Yondelis (Trabectedin) in Patients With Advanced Relapsed Ovarian Cancer · 74 trials list this drug (9 active) | — | — | Malignant Ovarian Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00579501Phase 2 · completed Safety and Efficacy Study of Trabectedin for the Treatment of Localized Myxoid / Round Cell Liposarcoma · 74 trials list this drug (9 active) | — | — | Myxoid Liposarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00786838Phase 2 · completed A Study to Assess the Potential Effects of a Single-Dose Administration of Trabectedin on the QT Intervals of the Electrocardiogram · 74 trials list this drug (9 active) | — | — | Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00072670Phase 2 · completed A Phase 2 Study of Trabectedin (Yondelis) in Adult Male Participants With Advanced Prostate Cancer · 74 trials list this drug (9 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00580112Phase 2 · completed An Efficacy Study of Trabectedin in the Treatment of Participants With Specific Subtypes of Metastatic Breast Cancer · 74 trials list this drug (9 active) | — | — | Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00006463Phase 1 · completed Ecteinascidin 743 in Treating Children With Refractory Solid Tumors · 74 trials list this drug (9 active) | — | — | Childhood Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00017030Phase 2 · completed Ecteinascidin 743 in Treating Patients With Unresectable Advanced or Metastatic Soft Tissue Sarcoma · 74 trials list this drug (9 active) | — | — | Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00005625Phase 2 · completed Ecteinascidin 743 in Treating Patients With Previously Treated Metastatic Osteosarcoma · 74 trials list this drug (9 active) | — | — | Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01772979Phase 2 · unknown Study With Trabectedin in BRCA1 and BRCA2 Mutation Carrier and BRCAness Phenotype Ovarian Cancer · 74 trials list this drug (9 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00147212Phase 2 · completed ET 743 (Yondelis) in Men With Advanced Prostate Cancer · 74 trials list this drug (9 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00050414Phase 2 · completed A Study of Trabectedin in Patients With Advanced Ovarian Cancer · 74 trials list this drug (9 active) | — | — | Neoplasm,Neoplasm by Site,Ovarian Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00102609Phase 1 · completed A Safety Study Utilizing Yondelis and Doxorubicin in Patients With a Type of Cancer Called Soft Tissue Sarcoma · 74 trials list this drug (9 active) | — | — | Neoplasm,Connective and Soft Tissue Neoplasm,Sarcoma+1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00050440Phase 2 · completed Phase 2 Study of ET-743 (Trabectedin) in Patients With Persistent or Recurrent Endometrial Carcinoma · 74 trials list this drug (9 active) | — | — | Uterine Neoplasm,Endometrial Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00003939Phase 2 · completed Ecteinascidin 743 in Treating Patients With Advanced Soft Tissue Sarcoma · 74 trials list this drug (9 active) | — | — | Sarcoma,Gastrointestinal Stromal Tumor,Malignant Ovarian Neoplasm+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00002904Phase 1 · completed Ecteinascidin 743 in Treating Adults With Advanced Solid Tumors · 74 trials list this drug (9 active) | — | — | Adult Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01427582no longer available YONDELIS (Trabectedin) Single Patient Compassionate Use / Expanded Access · 74 trials list this drug (9 active) | — | — | Soft Tissue Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00050427Phase 2 · completed A Study of ET-743 (Trabectedin) in Patients With Advanced Breast Cancer · 74 trials list this drug (9 active) | — | — | Neoplasm,Neoplasm by Site,Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |